- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 1 | SGX Company Announcements | ||
| 24.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON THE PROPOSED TRANSFER OF 100% EQUITY INTEREST IN AN UPSTREAM SHAREHOLDER | 2 | SGX Company Announcements | ||
| 07.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 3 | SGX Company Announcements | ||
| 04.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::APPOINTMENT OF GENERAL MANAGER | 1 | SGX Company Announcements | ||
| 04.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY | 1 | SGX Company Announcements | ||
| 04.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 8TH BOARD MEETING FOR FY2026 | 1 | SGX Company Announcements | ||
| TIANJIN PHARMACEUTICAL DA REN TANG Aktie jetzt für 0€ handeln | |||||
| 31.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | - | SGX Company Announcements | ||
| 28.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF THE 1ST EXTRAORDINARY GENERAL MEETING OF THE COMPANY FOR FY2026 HELD ON 31 JULY 2026 | 1 | SGX Company Announcements | ||
| 26.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON CONVENING AN ONLINE CONFERENCE | - | SGX Company Announcements | ||
| 14.08. | Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Profit Retreats In H1 | 2 | RTTNews | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY | 1 | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::CONTINUOUS RISK ASSESSMENT REPORT OF TIANJIN PHARMACEUTICAL GROUP FINANCE CO., LTD. | 1 | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON THE DEPOSIT OF NET PROCEEDS AND THE USE OF NET PROCEEDS | 1 | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::SECOND QUARTER AND/OR HALF YEARLY RESULTS | 2 | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 7TH BOARD MEETING FOR FY2026 | 3 | SGX Company Announcements | ||
| 07.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE PROPOSED ENTRY INTO A WAREHOUSING AND LOGISTICS COOPERATION AS AN INTERESTED PERSON TRANSACTION | 2 | SGX Company Announcements | ||
| 07.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::THE PROPOSED ENTRY INTO AN ANNUAL DISTRIBUTION AGREEMENT AS AN INTERESTED PERSON TRANSACTION | 1 | SGX Company Announcements | ||
| 07.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 6TH BOARD MEETING FOR FY2026 | 2 | SGX Company Announcements | ||
| 07.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON RECEIPT OF DRUG REGISTRATION CERTIFICATE BY XINXIN PHARMACEUTICAL PLANT | 3 | SGX Company Announcements | ||
| 04.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::UPDATE ON THE IMPLEMENTATION OF THE SHAREHOLDING INCREASE PLAN BY THE CONTROLLING SHAREHOLDER | 1 | SGX Company Announcements |
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 139,30 | 0,00 % | Novo Nordisk gerät trotz GLP-1 unter Druck - warum Eli Lilly und Co. schon Milliarden in neue Plattformen investieren | ||
| TEVA PHARMACEUTICAL INDUSTRIES | 34,600 | -1,14 % | XFRA TEVA: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILTEVA PHARMACEUT.... ► Artikel lesen | |
| SINOPHARM | 1,649 | 0,00 % | Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed... ► Artikel lesen | |
| CSPC PHARMA | 1,105 | -1,60 % | CSPC PHARMA Announces Phase III Clinical Study Results of TG103 Injection Combined With Metformin at EASD 2026 | ||
| WUXI BIOLOGICS | 6,110 | -0,65 % | HSI Closes at 24,613, Up 89 pts; HSTI Closes at 4,253, Up 4 pts; CSPC PHARMA Up over 6%; WUXI BIO, WUXI APPTEC, GENSCRIPT BIO, H&H INTL HLDG Hit New Highs; Market Turnover Rises | ||
| OPKO HEALTH | 1,330 | -5,00 % | OPKO HEALTH, INC. - 8-K, Current Report | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 2,027 | -1,60 % | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion | SHANGHAI, Sept 7, 2026 - (ACN Newswire) - Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ('Fosun Pharma', stock code: 600196.SH; 02196.HK) today announced an H share repurchase plan, under which the... ► Artikel lesen | |
| GEDEON RICHTER | 33,620 | -1,00 % | Gedeon Richter stellt auf der "Next Step"-Konferenz eine Online-Plattform für transdiagnostische Global-Impression-Skalen und ein neues Buch für Betreuende vor | BUDAPEST, HU / ACCESS Newswire /
29. September 2026 / Gedeon Richter begrüßte 145 Teilnehmer aus 27 Ländern zur jüngsten Ausgabe von "Next Step", der internationalen Konferenz des Unternehmens... ► Artikel lesen | |
| DR REDDYS | 10,700 | -2,73 % | Dr Reddys Laboratories Ltd up for third straight session | ||
| BAYER | 44,940 | -1,01 % | 90 Milliarden US-Dollar bis 2030: Wie Bayer, Mesoblast und NurExone regenerative Medizin unterschiedlich entwickeln | ||
| MERCK KGAA | 136,90 | +1,82 % | Merck Aktie | Wichtige Durchschnittslinien durchbrochen | Analyse | ||
| NOVO NORDISK | 33,210 | -0,48 % | FDA extends review for Novo Nordisk's denecimig for hemophilia A | ||
| ETON PHARMACEUTICALS | 55,42 | 0,00 % | Eton Pharmaceuticals, Inc. - 8-K, Current Report | ||
| SANOFI | 71,08 | -0,03 % | Laufende Fusionskontrollverfahren: Sanofi, Paris/FR; Erwerb eines Minderheitsanteils an der Cheplapharm SE (Gemeinschaftsunternehmen mit der Braun Invest Holding GmbH, Greifswald) | Datum der Anmeldung:24.09.2026Aktenzeichen:B3-102/26Unternehmen:Sanofi, Paris/FR; Erwerb eines Minderheitsanteils an der Cheplapharm SE (Gemeinschaftsunternehmen mit der Braun Invest Holding GmbH, Greifswald)Produktmärkte:Arzneimittel... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 13,685 | -0,04 % | Generate Biomedicines, Inc.: Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of 'Armored' CAR T Therapy for Ovarian Cancer | Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter clinical trials First patient treated in new clinical... ► Artikel lesen |
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell -0,91 % bei einem Aktienkurs von 2,180 Euro. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD finden Sie auf Wallstreet Online.